-
Study aim
-
Determining the effect of perianal injection of dexmedetomidine compared to the effect of ketamine on pain and vomiting after perianal fistula surgery
-
Design
-
A clinical trial of three parallel groups with a control group, triple blinded, randomized, phase 3 on 153 patients. The rand function of Excel software was used for randomization.
-
Settings and conduct
-
Patients are assigned to three groups using randomization with Excel software. All patients are anesthetized in the same way. At the end of the operation, one group is injected with 1.5 μg/kg diluted dexmedetomidine, and the second group is injected with 0.5 mg/kg diluted ketamine around the fistula site. In the third group, medicine is not injected. The study is triple-blind, the researcher, the patient, and the evaluator will not know the type of drug. This study will be conducted in the central operating room of Ghaem Hospital in Mashhad.
-
Participants/Inclusion and exclusion criteria
-
This study was conducted on patients aged 18-70 years with American Society of Anesthesiologists(ASA) class I and II and candidates for perianal surgery (perianal fistula) who consented to participate in the study and did not have underlying diseases such as diabetes, high blood pressure, lung or heart problems.
-
Intervention groups
-
At the end of the operation, one group was injected with 1.5 micrograms/kg of dexmedetomidine diluted with 4 cc of distilled water by the surgeon around the fistula site locally (subcutaneously) and in the second group of ketamine 0.5 mg/kg diluted with 4 cc of distilled water. It is injected locally in the perianal area (under the skin) and in the third group no medicine is injected.
-
Main outcome variables
-
Pain intensity, time required for the first analgesic dose and total analgesic dose
Patient vomiting
Vital signs include Blood pressure, Heart rate and shivering after the operation